Ajanta Pharma Ltd
Pharmaceutical ManufacturingMaharashtra, India5001-10000 Employees
Ajanta Pharma Ltd is a pharmaceutical manufacturing company headquartered in Mumbai, India, employing between 5,001 and 10,000 people. It maintains a branded generic business in India and emerging markets, alongside a generic business in the United States. In India, it operates in cardiology, dermatology, ophthalmology, and pain management, and has recently expanded into nephrology and gynaecology, with its brands leading in several sub-therapeutic areas. In Emerging Markets, the company is active across Africa, South East Asia, West Asia, and the CIS, with broader therapeutic coverage including antimalarial, gastro, antibiotics, cardiology, dermatology, and pain management. As of March 30, 2026, Ajanta had 49 ANDA approvals, all of which are commercialised, and it is awaiting US FDA approval for 19 more, while planning to file 8–12 ANDAs annually. The company operates R&D facilities in Mumbai with over 850 scientists, and runs six formulation manufacturing facilities in India plus an API facility at Waluj; its flagship Paithan and Dahej facilities are US FDA approved.